179 related articles for article (PubMed ID: 31069961)
1. Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Monteiro AC; Muenzner JK; Andrade F; Rius FE; Ostalecki C; Geppert CI; Agaimy A; Hartmann A; Fujita A; Schneider-Stock R; Jasiulionis MG
Mol Oncol; 2019 Jun; 13(6):1433-1449. PubMed ID: 31069961
[TBL] [Abstract][Full Text] [Related]
2. Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
Vellinga TT; Kranenburg O; Frenkel N; Ubink I; Marvin D; Govaert K; van Schelven S; Hagendoorn J; Borel Rinkes IH
Ann Surg; 2017 Nov; 266(5):765-771. PubMed ID: 28742689
[TBL] [Abstract][Full Text] [Related]
3. MET expression in melanoma correlates with a lymphangiogenic phenotype.
Swoboda A; Schanab O; Tauber S; Bilban M; Berger W; Petzelbauer P; Mikula M
Hum Mol Genet; 2012 Aug; 21(15):3387-96. PubMed ID: 22570180
[TBL] [Abstract][Full Text] [Related]
4. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
[TBL] [Abstract][Full Text] [Related]
5. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
Zheng CL; Qiu C; Shen MX; Qu X; Zhang TH; Zhang JH; Du JJ
Asian Pac J Cancer Prev; 2015; 16(5):1881-95. PubMed ID: 25773840
[TBL] [Abstract][Full Text] [Related]
7. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
Martinelli S; Kanduri M; Maffei R; Fiorcari S; Bulgarelli J; Marasca R; Rosenquist R
Epigenetics; 2013 Jul; 8(7):720-9. PubMed ID: 23803577
[TBL] [Abstract][Full Text] [Related]
8. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
9. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Trinh XB; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
J Pathol; 2007 Sep; 213(1):56-64. PubMed ID: 17674348
[TBL] [Abstract][Full Text] [Related]
10. ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients.
Lu J; Tang Y; Cheng Y; Zhang G; Yip A; Martinka M; Dong Z; Zhou J; Li G
Br J Cancer; 2013 Nov; 109(11):2842-52. PubMed ID: 24157826
[TBL] [Abstract][Full Text] [Related]
11. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
12. Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Gore J; Imasuen-Williams IE; Conteh AM; Craven KE; Cheng M; Korc M
Cancer Lett; 2016 Aug; 379(1):143-53. PubMed ID: 27267807
[TBL] [Abstract][Full Text] [Related]
13. Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assays.
Kaehler KC; Politz O; Henderson D; Ulbrich HF; Hauschild A; Mund C; Egberts F
Melanoma Res; 2015 Jun; 25(3):225-31. PubMed ID: 25919928
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
15. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
16. Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma.
Das AM; Koljenović S; Oude Ophuis CM; van der Klok T; Galjart B; Nigg AL; van Cappellen WA; Noordhoek Hegt V; Dinjens WN; Atmodimedjo PN; Vermeulen CE; Verhoef C; Eggermont AM; ten Hagen TL
Eur J Cancer; 2016 Jan; 53():135-43. PubMed ID: 26707830
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
Wouters J; Vizoso M; Martinez-Cardus A; Carmona FJ; Govaere O; Laguna T; Joseph J; Dynoodt P; Aura C; Foth M; Cloots R; van den Hurk K; Balint B; Murphy IG; McDermott EW; Sheahan K; Jirström K; Nodin B; Mallya-Udupi G; van den Oord JJ; Gallagher WM; Esteller M
BMC Med; 2017 Jun; 15(1):101. PubMed ID: 28578692
[TBL] [Abstract][Full Text] [Related]
18. JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma.
Lu J; Tang Y; Farshidpour M; Cheng Y; Zhang G; Jafarnejad SM; Yip A; Martinka M; Dong Z; Zhou J; Xu J; Li G
Carcinogenesis; 2013 Dec; 34(12):2778-88. PubMed ID: 24064223
[TBL] [Abstract][Full Text] [Related]
19. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.
Ma C; Yin H; Zhong J; Zhang Y; Luo C; Che D; Fang Z; Li L; Qin S; Liang J; Qi W; Yang Z; Zhou T; Ma J; Yang X; Gao G
Int J Oncol; 2017 Jun; 50(6):2000-2010. PubMed ID: 28440474
[TBL] [Abstract][Full Text] [Related]
20. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
